Harry Paul Erba
Professor of MedicineOverview
I am a clinical investigator in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine. I serve as Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies. I am also the Chair of the SWOG Leukemia Committee. I am interested in the clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia. Specifically, I have been the Principal Investigator for small molecular inhibitors, antibody-drug conjugates and cytotoxic chemotherapy.
Positions
Professor of Medicine in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2018 School of Medicine
Education
Ph.D., Stanford University 1988
1988 Stanford University
M.D., Stanford University, School of Medicine 1988
1988 Stanford University, School of Medicine
Clinical Fellow in Medicine, Harvard Medical School, MEDICINE 1988 - 1991
1991 Harvard Medical School
Residency Physician, Brigham and Women's Hospital, MEDICINE 1988 - 1990
1990 Brigham and Women's Hospital
Research/Clinical Fellowship in Medicine, Brigham and Women's Hospital, MEDICINE 1991 - 1992
1992 Brigham and Women's Hospital
Research Fellowship in Medicine, Harvard Medical School, MEDICINE 1991 - 1993
1993 Harvard Medical School
Publications, Grants & Awards
DCI Centers, Cancer Types & Labs
Offices & Contact
2400 Pratt St Suite 5000
Durham, NC
27710
DUMC Box 3961
Durham, NC
27710